Drug candidate and target for leishmaniasis

Drug candidate and target for leishmaniasis

Better treatments are needed for the neglected tropical disease leishmaniasis. The development of a compound that tackles the disease in mice, and the identification of the protein it targets, offer a way forward. Better treatments are needed for the neglected tropical disease leishmaniasis. The dev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature (London) 2018-08, Vol.560 (7717), p.171-172
Hauptverfasser: Catta-Preta, Carolina M. C., Mottram, Jeremy C.
Format: Artikel
Sprache:eng
Schlagworte:
631/326
692/308
Cyclins
Disease transmission
Drug Delivery Systems
Drug therapy
Drugs
Health
Humans
Kinases
Leishmaniasis
Leishmaniasis, Visceral
Mutation
News And Views
Parasite resistance
Parasites
Parasitic diseases
Pharmaceutical industry
Public health
Tropical diseases
Vector-borne diseases
Visceral leishmaniasis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Better treatments are needed for the neglected tropical disease leishmaniasis. The development of a compound that tackles the disease in mice, and the identification of the protein it targets, offer a way forward. Better treatments are needed for the neglected tropical disease leishmaniasis. The development of a compound that tackles the disease in mice, and the identification of the protein it targets, offer a way forward.
ISSN:0028-0836
1476-4687
DOI:10.1038/d41586-018-05765-y